Literature DB >> 21446578

Has the answer to diagnosing TB in resource-limited settings been found?

Chawangwa Modongo1, Nicola M Zetola, Mark Pandori, Jeffrey D Klausner.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21446578      PMCID： PMC3786214     

Source DB:  PubMed          Journal:  MLO Med Lab Obs        ISSN： 0580-7247


× No keyword cloud information.
  8 in total

1.  Tuberculosis diagnosis--time for a game change.

Authors:  Peter M Small; Madhukar Pai
Journal:  N Engl J Med       Date:  2010-09-01       Impact factor: 91.245

Review 2.  Xpert(®) MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope?

Authors:  Annelies Van Rie; Liesl Page-Shipp; Lesley Scott; Ian Sanne; Wendy Stevens
Journal:  Expert Rev Mol Diagn       Date:  2010-10       Impact factor: 5.225

3.  Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings.

Authors:  Padmapriya P Banada; Satheesh K Sivasubramani; Robert Blakemore; Catharina Boehme; Mark D Perkins; Kevin Fennelly; David Alland
Journal:  J Clin Microbiol       Date:  2010-08-18       Impact factor: 5.948

4.  Evaluation of the analytical performance of the Xpert MTB/RIF assay.

Authors:  Robert Blakemore; Elizabeth Story; Danica Helb; JoAnn Kop; Padmapriya Banada; Michelle R Owens; Soumitesh Chakravorty; Martin Jones; David Alland
Journal:  J Clin Microbiol       Date:  2010-05-26       Impact factor: 5.948

5.  Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system.

Authors:  Doris Hillemann; Sabine Rüsch-Gerdes; Catharina Boehme; Elvira Richter
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

6.  Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens.

Authors:  Elizabeth M Marlowe; Susan M Novak-Weekley; Joven Cumpio; Susan E Sharp; Michelle A Momeny; Anna Babst; Jonathan S Carlson; Masae Kawamura; Mark Pandori
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

7.  Rapid molecular detection of tuberculosis and rifampin resistance.

Authors:  Catharina C Boehme; Pamela Nabeta; Doris Hillemann; Mark P Nicol; Shubhada Shenai; Fiorella Krapp; Jenny Allen; Rasim Tahirli; Robert Blakemore; Roxana Rustomjee; Ana Milovic; Martin Jones; Sean M O'Brien; David H Persing; Sabine Ruesch-Gerdes; Eduardo Gotuzzo; Camilla Rodrigues; David Alland; Mark D Perkins
Journal:  N Engl J Med       Date:  2010-09-01       Impact factor: 91.245

8.  Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology.

Authors:  Danica Helb; Martin Jones; Elizabeth Story; Catharina Boehme; Ellen Wallace; Ken Ho; JoAnn Kop; Michelle R Owens; Richard Rodgers; Padmapriya Banada; Hassan Safi; Robert Blakemore; N T Ngoc Lan; Edward C Jones-López; Michael Levi; Michele Burday; Irene Ayakaka; Roy D Mugerwa; Bill McMillan; Emily Winn-Deen; Lee Christel; Peter Dailey; Mark D Perkins; David H Persing; David Alland
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948
  8 in total
  1 in total

1.  Feasibility of Chlamydia trachomatis screening and treatment in pregnant women in Lima, Peru: a prospective study in two large urban hospitals.

Authors:  Jeanne Cabeza; Patricia J García; Eddy Segura; Pedro García; Francisco Escudero; Sayda La Rosa; Segundo León; Jeffrey D Klausner
Journal:  Sex Transm Infect       Date:  2014-08-08       Impact factor: 3.519
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.